Belinda Hsi Dickie, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anus, Imperforate | 7 | 2023 | 66 | 2.890 |
Why?
|
| Rectum | 11 | 2023 | 903 | 1.980 |
Why?
|
| Hirschsprung Disease | 7 | 2023 | 155 | 1.870 |
Why?
|
| Fecal Incontinence | 11 | 2024 | 240 | 1.870 |
Why?
|
| Cloaca | 4 | 2021 | 52 | 1.690 |
Why?
|
| Anal Canal | 12 | 2023 | 376 | 1.620 |
Why?
|
| Rectal Fistula | 6 | 2023 | 73 | 1.480 |
Why?
|
| Urogenital Abnormalities | 4 | 2021 | 261 | 1.380 |
Why?
|
| Enterocolitis | 4 | 2023 | 102 | 1.180 |
Why?
|
| Lymphatic Abnormalities | 2 | 2018 | 133 | 1.000 |
Why?
|
| Hernia, Umbilical | 2 | 2021 | 96 | 0.890 |
Why?
|
| Hemangioma | 3 | 2020 | 737 | 0.870 |
Why?
|
| Fistula | 2 | 2023 | 218 | 0.860 |
Why?
|
| Laparoscopy | 3 | 2024 | 2121 | 0.820 |
Why?
|
| Urethra | 2 | 2020 | 408 | 0.790 |
Why?
|
| Hemangioendothelioma | 2 | 2018 | 121 | 0.760 |
Why?
|
| Vascular Malformations | 3 | 2023 | 450 | 0.750 |
Why?
|
| Digestive System Surgical Procedures | 3 | 2023 | 576 | 0.730 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2022 | 150 | 0.720 |
Why?
|
| Lymphangiectasis | 1 | 2018 | 17 | 0.670 |
Why?
|
| Vascular Neoplasms | 1 | 2020 | 175 | 0.660 |
Why?
|
| Sarcoma, Kaposi | 2 | 2018 | 370 | 0.640 |
Why?
|
| Urologic Surgical Procedures | 1 | 2020 | 301 | 0.620 |
Why?
|
| Colostomy | 4 | 2024 | 98 | 0.610 |
Why?
|
| Lymphangiogenesis | 2 | 2017 | 172 | 0.590 |
Why?
|
| Endothelial Cells | 4 | 2018 | 3455 | 0.580 |
Why?
|
| Lymphoid Tissue | 1 | 2018 | 455 | 0.550 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2018 | 890 | 0.550 |
Why?
|
| Pericytes | 1 | 2018 | 291 | 0.540 |
Why?
|
| Intestinal Volvulus | 1 | 2016 | 65 | 0.520 |
Why?
|
| Abnormalities, Multiple | 4 | 2020 | 1416 | 0.510 |
Why?
|
| Alleles | 2 | 2018 | 6931 | 0.510 |
Why?
|
| Scoliosis | 2 | 2021 | 719 | 0.500 |
Why?
|
| Constipation | 5 | 2023 | 546 | 0.490 |
Why?
|
| Rectal Prolapse | 3 | 2023 | 30 | 0.480 |
Why?
|
| Infant | 20 | 2023 | 35070 | 0.470 |
Why?
|
| Enema | 5 | 2024 | 141 | 0.470 |
Why?
|
| Esophageal Atresia | 2 | 2014 | 201 | 0.460 |
Why?
|
| Esophageal Cyst | 1 | 2013 | 13 | 0.460 |
Why?
|
| Perioperative Care | 1 | 2020 | 997 | 0.440 |
Why?
|
| Ultrasonography | 3 | 2020 | 5978 | 0.410 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2013 | 129 | 0.400 |
Why?
|
| Down Syndrome | 2 | 2023 | 880 | 0.370 |
Why?
|
| Liver Neoplasms | 3 | 2020 | 4249 | 0.370 |
Why?
|
| Intestinal Obstruction | 1 | 2013 | 424 | 0.350 |
Why?
|
| Muscle, Smooth | 1 | 2013 | 933 | 0.340 |
Why?
|
| Retrospective Studies | 27 | 2024 | 77098 | 0.340 |
Why?
|
| Contrast Media | 2 | 2020 | 5295 | 0.340 |
Why?
|
| Child, Preschool | 17 | 2023 | 40955 | 0.320 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1782 | 0.320 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 2633 | 0.320 |
Why?
|
| Postoperative Complications | 8 | 2023 | 15244 | 0.310 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1625 | 0.310 |
Why?
|
| Image Enhancement | 1 | 2019 | 2921 | 0.310 |
Why?
|
| Limb Deformities, Congenital | 2 | 2022 | 136 | 0.300 |
Why?
|
| Colorectal Neoplasms | 3 | 2022 | 6754 | 0.290 |
Why?
|
| Appendix | 2 | 2019 | 110 | 0.290 |
Why?
|
| Patient Satisfaction | 2 | 2018 | 3391 | 0.280 |
Why?
|
| Infant, Newborn | 10 | 2023 | 25575 | 0.280 |
Why?
|
| Fluoroscopy | 2 | 2020 | 924 | 0.270 |
Why?
|
| Sclerotherapy | 2 | 2023 | 175 | 0.260 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 2938 | 0.250 |
Why?
|
| Cell Proliferation | 2 | 2018 | 10472 | 0.230 |
Why?
|
| Urinary Fistula | 1 | 2023 | 41 | 0.230 |
Why?
|
| Child | 23 | 2023 | 77478 | 0.220 |
Why?
|
| Urethral Diseases | 1 | 2023 | 53 | 0.220 |
Why?
|
| Humans | 51 | 2024 | 742088 | 0.210 |
Why?
|
| Bladder Exstrophy | 1 | 2023 | 106 | 0.210 |
Why?
|
| Female | 33 | 2023 | 379592 | 0.200 |
Why?
|
| Laxatives | 2 | 2022 | 87 | 0.200 |
Why?
|
| Treatment Outcome | 13 | 2023 | 62966 | 0.200 |
Why?
|
| Thoracotomy | 2 | 2013 | 363 | 0.180 |
Why?
|
| Delayed Diagnosis | 1 | 2023 | 438 | 0.180 |
Why?
|
| Enterostomy | 1 | 2019 | 14 | 0.170 |
Why?
|
| Mouth Mucosa | 1 | 2022 | 434 | 0.170 |
Why?
|
| Vagina | 2 | 2022 | 825 | 0.160 |
Why?
|
| Male | 26 | 2023 | 349538 | 0.160 |
Why?
|
| Sirolimus | 2 | 2016 | 1562 | 0.160 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2022 | 336 | 0.160 |
Why?
|
| Heart Defects, Congenital | 3 | 2022 | 4566 | 0.160 |
Why?
|
| Senna Extract | 1 | 2017 | 3 | 0.160 |
Why?
|
| Ankyrins | 1 | 2018 | 128 | 0.150 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2019 | 337 | 0.150 |
Why?
|
| Ribonucleotides | 1 | 2018 | 117 | 0.150 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2018 | 88 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2018 | 126 | 0.150 |
Why?
|
| Urinary Incontinence | 1 | 2021 | 494 | 0.150 |
Why?
|
| Phenotype | 1 | 2014 | 16331 | 0.140 |
Why?
|
| Nevus, Blue | 1 | 2016 | 38 | 0.140 |
Why?
|
| Dermis | 1 | 2017 | 207 | 0.140 |
Why?
|
| Colorectal Surgery | 1 | 2018 | 129 | 0.140 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2019 | 448 | 0.130 |
Why?
|
| Antigens, Differentiation | 1 | 2018 | 926 | 0.130 |
Why?
|
| E-Selectin | 1 | 2018 | 579 | 0.130 |
Why?
|
| Adolescent | 11 | 2023 | 85649 | 0.130 |
Why?
|
| Heme Oxygenase-1 | 1 | 2018 | 381 | 0.130 |
Why?
|
| Health Status Indicators | 2 | 2018 | 968 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 1 | 2018 | 611 | 0.130 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 377 | 0.130 |
Why?
|
| Interleukin-8 | 1 | 2018 | 689 | 0.130 |
Why?
|
| Colon | 4 | 2023 | 1773 | 0.130 |
Why?
|
| Cystic Fibrosis | 1 | 2023 | 1178 | 0.120 |
Why?
|
| Quality of Life | 6 | 2018 | 12730 | 0.120 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2018 | 608 | 0.120 |
Why?
|
| Syndrome | 1 | 2020 | 3248 | 0.120 |
Why?
|
| Naphthyridines | 1 | 2014 | 118 | 0.120 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2016 | 189 | 0.120 |
Why?
|
| Rectovaginal Fistula | 1 | 2013 | 11 | 0.110 |
Why?
|
| Wnt Proteins | 1 | 2017 | 721 | 0.110 |
Why?
|
| Esophagoplasty | 1 | 2013 | 43 | 0.110 |
Why?
|
| Lymphatic Vessels | 1 | 2017 | 351 | 0.110 |
Why?
|
| Specialties, Surgical | 1 | 2018 | 389 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 729 | 0.110 |
Why?
|
| Pediatrics | 2 | 2018 | 3462 | 0.110 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2020 | 1130 | 0.110 |
Why?
|
| Failure to Thrive | 1 | 2013 | 136 | 0.110 |
Why?
|
| Trachea | 2 | 2022 | 1075 | 0.110 |
Why?
|
| Myeloid Cells | 1 | 2017 | 804 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2016 | 692 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1683 | 0.100 |
Why?
|
| Reoperation | 4 | 2016 | 4200 | 0.100 |
Why?
|
| Perineum | 1 | 2013 | 211 | 0.100 |
Why?
|
| Rodentia | 1 | 2013 | 262 | 0.100 |
Why?
|
| Spine | 2 | 2022 | 1143 | 0.100 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2011 | 48 | 0.100 |
Why?
|
| Young Adult | 6 | 2022 | 56350 | 0.090 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2013 | 485 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2018 | 2451 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2020 | 1884 | 0.090 |
Why?
|
| Fundoplication | 1 | 2011 | 138 | 0.090 |
Why?
|
| Endoscopy | 1 | 2019 | 1774 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1887 | 0.090 |
Why?
|
| Mutation | 3 | 2019 | 29717 | 0.080 |
Why?
|
| Gastrostomy | 1 | 2011 | 309 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2013 | 1241 | 0.080 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2016 | 987 | 0.080 |
Why?
|
| Incidental Findings | 1 | 2013 | 688 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 2410 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2018 | 3199 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2018 | 2924 | 0.080 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2011 | 265 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2020 | 2789 | 0.080 |
Why?
|
| Bronchoscopy | 1 | 2013 | 860 | 0.080 |
Why?
|
| Length of Stay | 1 | 2020 | 6294 | 0.070 |
Why?
|
| Esophagus | 1 | 2013 | 1017 | 0.070 |
Why?
|
| Follow-Up Studies | 4 | 2023 | 39004 | 0.070 |
Why?
|
| Incidence | 4 | 2023 | 20928 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2018 | 3020 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2013 | 2215 | 0.070 |
Why?
|
| Comorbidity | 1 | 2020 | 10372 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 4029 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3691 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 4187 | 0.070 |
Why?
|
| Skin | 1 | 2019 | 4353 | 0.070 |
Why?
|
| Boston | 1 | 2018 | 9305 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2018 | 8297 | 0.060 |
Why?
|
| Gastroesophageal Reflux | 1 | 2011 | 782 | 0.060 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 1901 | 0.060 |
Why?
|
| Hypothyroidism | 1 | 2009 | 659 | 0.060 |
Why?
|
| Skin Neoplasms | 2 | 2016 | 5662 | 0.060 |
Why?
|
| Cell Line | 1 | 2018 | 15994 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2018 | 23387 | 0.060 |
Why?
|
| Kidney | 2 | 2022 | 7167 | 0.060 |
Why?
|
| Parents | 1 | 2016 | 3387 | 0.050 |
Why?
|
| Vulva | 1 | 2023 | 87 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 4147 | 0.050 |
Why?
|
| Constriction, Pathologic | 2 | 2019 | 1095 | 0.050 |
Why?
|
| Adult | 5 | 2022 | 213712 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 9826 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2011 | 2245 | 0.050 |
Why?
|
| Biological Factors | 1 | 2023 | 164 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2016 | 4229 | 0.050 |
Why?
|
| Telemedicine | 1 | 2018 | 2853 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2018 | 7873 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2019 | 53187 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 12071 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2009 | 2107 | 0.040 |
Why?
|
| Biopsy | 1 | 2011 | 6756 | 0.040 |
Why?
|
| Public Opinion | 1 | 2023 | 477 | 0.040 |
Why?
|
| Prognosis | 2 | 2016 | 29010 | 0.040 |
Why?
|
| Animals | 4 | 2021 | 168561 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 9410 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15530 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2018 | 12164 | 0.040 |
Why?
|
| Unnecessary Procedures | 2 | 2011 | 431 | 0.040 |
Why?
|
| Arteriovenous Malformations | 1 | 2019 | 396 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2021 | 1171 | 0.030 |
Why?
|
| Radiology, Interventional | 1 | 2019 | 460 | 0.030 |
Why?
|
| Defecation | 1 | 2016 | 188 | 0.030 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2018 | 395 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 18006 | 0.030 |
Why?
|
| Dyspareunia | 1 | 2013 | 50 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 8621 | 0.030 |
Why?
|
| Consensus | 1 | 2021 | 2935 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2017 | 1459 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2023 | 3300 | 0.020 |
Why?
|
| Critical Illness | 1 | 2023 | 2665 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2011 | 587 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 1188 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 4929 | 0.020 |
Why?
|
| Hospitals | 1 | 2023 | 3937 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2012 | 985 | 0.020 |
Why?
|
| Gastric Emptying | 1 | 2011 | 233 | 0.020 |
Why?
|
| Uterus | 1 | 2013 | 710 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2010 | 520 | 0.020 |
Why?
|
| Psychometrics | 1 | 2018 | 2999 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2011 | 981 | 0.020 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2011 | 273 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2016 | 3913 | 0.020 |
Why?
|
| Pain | 1 | 2023 | 4961 | 0.020 |
Why?
|
| Colectomy | 1 | 2012 | 681 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 13019 | 0.020 |
Why?
|
| Risk Factors | 3 | 2023 | 72145 | 0.020 |
Why?
|
| Radiography | 1 | 2017 | 7010 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 2552 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 13655 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2011 | 880 | 0.020 |
Why?
|
| Caregivers | 1 | 2016 | 2074 | 0.020 |
Why?
|
| Heart Failure | 1 | 2009 | 10856 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2010 | 1484 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 1952 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12773 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 24913 | 0.010 |
Why?
|
| Algorithms | 2 | 2012 | 13853 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7276 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19862 | 0.010 |
Why?
|
| Sarcoma | 1 | 2011 | 1895 | 0.010 |
Why?
|
| Carcinoma | 1 | 2011 | 2374 | 0.010 |
Why?
|
| Hematologic Neoplasms | 1 | 2011 | 1820 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13256 | 0.010 |
Why?
|
| Age Factors | 1 | 2016 | 18355 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 21719 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2011 | 2211 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2011 | 2522 | 0.010 |
Why?
|
| Prevalence | 1 | 2014 | 15194 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 15056 | 0.010 |
Why?
|
| Melanoma | 1 | 2011 | 5462 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 81045 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 20086 | 0.000 |
Why?
|
| Middle Aged | 1 | 2013 | 213127 | 0.000 |
Why?
|